Regeneron Pharmaceuticals, Inc.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US75886F1075
USD
722.80
-19.2 (-2.59%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
3,675.60
3,028.70
3,789.20
3,720.70
3,547.10
3,145.00
3,434.30
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,675.60
3,028.70
3,789.20
3,720.70
3,547.10
3,145.00
3,434.30
Raw Material Cost
665.30
591.20
691.50
612.80
600.90
547.90
629.10
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
449.40
451.60
0.00
407.80
422.50
418.90
406.30
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.60
8.70
10.50
13.80
14.80
16.10
18.30
Selling and Distribution Expenses
634.20
633.00
783.70
714.40
758.80
689.00
704.40
Other Expenses
83.36
74.02
126.14
72.82
64.20
69.93
62.60
Total Expenditure (Excl Depreciation)
2,586.10
2,424.70
2,747.10
2,477.00
2,439.00
2,371.20
2,384.10
Operating Profit (PBDIT) excl Other Income
1089.5
604
1042.1
1243.7
1108.1
773.8
1050.2
Other Income
193.00
182.30
191.50
192.80
180.80
161.60
134.90
Operating Profit (PBDIT)
1,417.60
913.20
1,344.50
1,550.20
1,395.00
1,034.20
1,298.60
Interest
3.60
8.70
10.50
13.80
14.80
16.10
18.30
Exceptional Items
239.80
127.40
-249.50
78.30
368.60
-203.30
-19.70
Gross Profit (PBDT)
3,010.30
2,437.50
3,097.70
3,107.90
2,946.20
2,597.10
2,805.20
Depreciation
135.10
126.90
126.40
121.70
120.70
114.10
113.00
Profit Before Tax
1,518.70
905.00
958.10
1,493.00
1,628.10
700.70
1,147.60
Tax
127.10
96.30
40.40
152.40
195.80
-21.30
-12.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,391.60
808.70
917.70
1,340.60
1,432.30
722.00
1,159.60
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,391.60
808.70
917.70
1,340.60
1,432.30
722.00
1,159.60
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,391.60
808.70
917.70
1,340.60
1,432.30
722.00
1,159.60
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
29,938.90
29,387.60
29,353.60
29,325.90
28,205.80
26,991.10
25,973.10
Earnings per share (EPS)
12.81
7.27
8.06
11.54
12.41
6.27
10.19
Diluted Earnings per share
12.81
7.27
8.06
11.54
12.41
6.27
10.19
Operating Profit Margin (Excl OI)
29.64%
19.94%
27.09%
33.21%
30.83%
24.12%
30.59%
Gross Profit Margin
44.99%
34.07%
28.62%
43.4%
49.3%
25.91%
36.71%
PAT Margin
37.86%
26.7%
24.22%
36.03%
40.38%
22.96%
33.77%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 21.36% vs -20.07% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is 72.08% vs -11.88% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is 67.55% vs -36.61% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is -58.62% vs -17.14% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

Compare Quarterly Results Of Regeneron Pharmaceuticals, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
3,675.60
2,986.00
689.60
23.09%
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,675.60
2,986.00
689.60
23.09%
Raw Material Cost
665.30
407.50
257.80
63.26%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
449.40
0.00
449.40
Power Cost
0
0
0.00
Manufacturing Expenses
3.60
3.70
-0.10
-2.70%
Selling and Distribution Expenses
634.20
424.60
209.60
49.36%
Other Expenses
83.36
97.47
-14.11
-14.48%
Total Expenditure (Excl Depreciation)
2,586.10
1,810.50
775.60
42.84%
Operating Profit (PBDIT) excl Other Income
1,089.50
1,175.50
-86.00
-7.32%
Other Income
193.00
111.00
82.00
73.87%
Operating Profit (PBDIT)
1,417.60
1,338.20
79.40
5.93%
Interest
3.60
3.70
-0.10
-2.70%
Exceptional Items
239.80
0.20
239.60
119,800.00%
Gross Profit (PBDT)
3,010.30
2,578.50
431.80
16.75%
Depreciation
135.10
51.70
83.40
161.32%
Profit Before Tax
1,518.70
1,283.00
235.70
18.37%
Tax
127.10
250.10
-123.00
-49.18%
Provisions and contingencies
0
0
0.00
Profit After Tax
1,391.60
1,032.90
358.70
34.73%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,391.60
1,032.90
358.70
34.73%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,391.60
1,032.90
358.70
34.73%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
29,938.90
17,175.40
12,763.50
74.31%
Earnings per share (EPS)
12.81
3.99
8.82
221.05%
Diluted Earnings per share
12.81
3.99
8.82
221.05%
Operating Profit Margin (Excl OI)
29.64%
39.37%
0.00
-9.73%
Gross Profit Margin
44.99%
44.70%
0.00
0.29%
PAT Margin
37.86%
34.59%
0.00
3.27%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 367.56 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 21.36% vs -20.07% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 3.62% vs 12.32% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 139.16 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 72.08% vs -11.88% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -2.84% vs 47.90% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 122.46 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 67.55% vs -36.61% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 0.86% vs 8.45% in Jun 2024

Quarterly - Interest
Interest 0.36 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -58.62% vs -17.14% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -75.68% vs -21.69% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 29.64%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024